Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Mayo Clinic Minnesota

Rochester, Minnesota 55905, United StatesNot linked to an institution yet

23running trials
10closed trials

The trials here

What the 33 trials at this site are about, from their registry records.

Conditions: Alzheimer disease2 trials
Cervical cancer2 trials
Chronic lymphocytic leukaemia2 trials
Colorectal cancer2 trials
Endometrial cancer2 trials
Epilepsy2 trials
Gastric and oesophageal cancer2 trials
Head and neck cancer2 trials
Lung cancer2 trials
Melanoma2 trials
Migraine2 trials
Multiple myeloma2 trials
and 23 more
Phase: Phase 29 trials
Phase 1/24 trials
Phase 42 trials
Phase 2/31 trial
Phase 31 trial
Status: Completed9 trials
Active, not recruiting8 trials
Recruiting8 trials
Enrolling by invitation6 trials
Not yet recruiting1 trial
Terminated1 trial
Lead sponsor: Mayo Clinic22 trials
Eli Lilly and Company2 trials
Aminex Therapeutics, Inc.1 trial
Artios Pharma Ltd1 trial
AskBio Inc1 trial
and 6 more

Running trials

Recruiting
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
NCT06333652· Phase 2· Mayo Clinic· Source
Contact: Maria L. Gonzalez Suarez, MD,PhD
Recruiting
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
NCT07284758· Phase 2· C4 Therapeutics, Inc.· Source
Contact: Wilson Gonsalves, MD
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
NCT06876649· Phase 4· Eli Lilly and Company· Source
Contact: Yucai Wang (principal investigator)
Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
NCT06876662· Phase 4· Eli Lilly and Company· Source
Contact: Yucai Wang (principal investigator)
Recruiting
A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
NCT06006884· Mayo Clinic· Source
Contact: Chris Roberts
Active, not recruiting
Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
NCT06106295· Phase 2· Mayo Clinic· Source
Active, not recruiting
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
NCT05598333· Phase 2· AskBio Inc· Source
Enrolling by invitation
MR Elastography of Cognitive Impairment
NCT06029114· Mayo Clinic· Source
Active, not recruiting
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
NCT05739162· Mayo Clinic· Source
Enrolling by invitation
A Study of Renal Microvessel Imaging for Chronic Kidney Disease
NCT05764642· Phase 2· Mayo Clinic· Source
Enrolling by invitation
A Study of Imaging in Demyelinating Diseases
NCT05805839· Phase 2· Mayo Clinic· Source
Enrolling by invitation
A Study of Wearable Device in Essential Tremor Patients
NCT05976074· Mayo Clinic· Source
Recruiting
Study of Transcranial Direct Current Stimulation to Treat Epilepsy
NCT05673915· Mayo Clinic· Source
Contact: Precylla Ruiz
Enrolling by invitation
A Study to Assess the Accuracy of Magnetocardiography (MCG) to Diagnose True Ischemia in Patients With Chest Pain in the ED
NCT05809648· Mayo Clinic· Source
Active, not recruiting
A Study of Time Restricted Eating in Obese Adults
NCT05660291· Mayo Clinic· Source
Active, not recruiting
A Study of Wearable Devices to Predict Migraines
NCT05755945· Mayo Clinic· Source
Active, not recruiting
Statins for the Treatment of NASH
NCT04679376· Phase 2· Mayo Clinic· Source
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT05549297· Phase 3· Immunocore Ltd· Source
Active, not recruiting
Registry for Mayo Clinic Adult Congenital Heart Disease Control Population
NCT05773300· Mayo Clinic· Source
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068· Phase 1/2· Artios Pharma Ltd· Source
Contact: Sarah Cannon Development Innovations
Active, not recruiting
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
NCT04069273· Phase 2· Harry H Yoon· Source
Enrolling by invitation
Neuroimaging Study
NCT03618186· Phase 2· Mayo Clinic· Source
Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
NCT03013998· Phase 2/3· Beat AML, LLC· Source
Contact: Aref Al-Kali, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Completed
A Study of Hemp Hull WFI for IBS Diarrhea
NCT06028035· Mayo Clinic· Source
Completed
A Study of MUSE Device for Midlife Women
NCT05972486· Mayo Clinic· Source
Completed
A Study of Spoken Language in Mania
NCT05956340· Mayo Clinic· Source
Completed
A Study to Detect Advanced Liver Disease Via AI-enabled Electrocardiogram
NCT05782283· Mayo Clinic· Source
Terminated
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
NCT05500508· Phase 1/2· Aminex Therapeutics, Inc.· Source
Completed
Patient Self-sampling of HPV to Screen for Cervical Cancer
NCT05600283· Mayo Clinic· Source
Completed
Study of DF9001 in Patients With Advanced Solid Tumors
NCT05597839· Phase 1/2· Dragonfly Therapeutics· Source
Completed
Wearable Devices to Monitor Seizures in Autoimmune Epilepsy
NCT05627661· Mayo Clinic· Source
Completed
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
NCT05854992· Mayo Clinic· Source
Completed
Myeloma-Developing Regimens Using Genomics (MyDRUG)
NCT03732703· Phase 1/2· Multiple Myeloma Research Consortium· Source

Site data: ClinicalTrials.govUpdated 13 Nov 2026

Report an error

Under construction, not live – Mayo Clinic Minnesota: trial site – Frontlight Research